Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fed Conditions
This research study is looking at two different versions of a medicine called Lenvatinib, which is usually given as a 10 mg capsule. One is the widely known Lenvima® capsule, and the other is a new, similar version. The main goal is to find out if these two capsules act in exactly the same way inside the body when taken by healthy volunteers after they've eaten a meal. This type of study, called a bioequivalence study, is crucial. It helps ensure that any new version of a medication is just as safe and effective as the original. By comparing them, scientists can confirm that the body absorbs and processes the new capsule in the same way, making sure patients get the correct amount of medicine.
At a glance
What is this study about?
Imagine you have a key, and you need a spare. You want the spare key to open the door just as smoothly as the original, right? This study is a bit like that, but for medicine. Researchers are comparing two versions of a 10 mg capsule that contains a medicine called Lenvatinib. One is the branded medicine, Lenvima®, and the other is a new, similar capsule. The main aim is to check if these two capsules behave exactly the same way once they are inside a healthy person's body after they've had a meal.
This kind of study is called a 'bioequivalence' study. 'Bio' means life, and 'equivalence' means equal. So, it's about seeing if two medicines are biologically equal. Scientists need to be absolutely sure that if a new version of a medicine is made, it works in precisely the same way as the original. This means that a new capsule should release the medicine into your bloodstream at the same speed and to the same extent as the original.
Why does this matter? Well, it's really important for making sure that patients always receive the correct dose and effect from their medication, no matter which version they get. If the new capsule is proven to be bioequivalent, it means doctors can be confident prescribing it, knowing it will work just as expected. This step is a standard and vital part of developing and approving new medicines, ensuring safety and effectiveness for everyone.
Key takeaways
- This study compares a new Lenvatinib capsule with the original Lenvima® capsule.
- It aims to confirm both capsules work identically in the body after eating.
- Only healthy adults aged 18 and over, both men and women, can join.
- Participation involves taking the capsule, blood tests, and health checks.
- The study helps ensure new medicines are safe and effective for patients.
Who may be eligible?
This study is looking for healthy adults to take part. This means you shouldn't have any current medical conditions or long-term health problems. Researchers want to make sure that any effects seen are purely from the medicine and not from an existing illness.
You need to be at least 18 years old to join. There isn't an upper age limit mentioned, so older adults can also be considered as long as they are generally healthy. Both men and women are welcome to participate in this study. The researchers will check your health carefully to ensure it's safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy with no ongoing medical conditions?
- Are you happy to take medication and have blood tests?
- Are you available for multiple study visits?
- Are you a man or a woman?
What does participation involve?
If you join this study, you will be given one of the two versions of the Lenvatinib 10 mg capsule. You will take this capsule after eating a meal. The research team will then monitor your health closely, and take blood samples at specific times to see how the medicine is absorbed and processed by your body. You will likely visit the study site for several days or periods, and there will be follow-up health checks. The total duration of your participation, including all visits and follow-ups, will be explained in full detail by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What is Lenvatinib normally used for?
Lenvatinib (Lenvima®) is a medicine usually used to treat certain types of cancer, but this study is testing it in healthy people, not sick patients.
Why do you need healthy people for this study?
The study needs healthy volunteers to see how the medicine works in a typical body without any illnesses getting in the way or affecting the results.
Will I know which capsule I'm taking?
The study team will explain if you will know which capsule you are taking. Sometimes, participants don't know to keep the results fair and unbiased.
Will I get paid for taking part?
It's common for healthy volunteer studies to offer payment for your time and travel, but you should ask the study team for details.
How long will I be involved in the study?
The study length can vary. The researchers will give you a detailed schedule of how many visits and how much time is needed for your participation.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.